US FDA Advisory Committees: Flipping FDAAA Mandate On Its Head
Executive Summary
FDA’s use of advisory committees is at a historic low – as are the prospects of sponsors getting a positive outcome. Is it COVID? Or a more fundamental shift in how FDA uses its panels?